LI3 Stock Chart & Stats
€59.20
€0.35(1.53%)
At close: 4:00 PM EST
€59.20
€0.35(1.53%)
Day’s Range― - ―
52-Week Range€38.70 - €70.40
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€3.04B
Enterprise Value€3.34K
Total Cash (Recent Filing)€246.76M
Total Debt (Recent Filing)€511.81M
Price to Earnings (P/E)18.7
Beta0.69
Next Earnings
Feb 18, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)3.58
Shares Outstanding46,538,315
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.12
Price to Book (P/B)2.23
Price to Sales (P/S)1.39
P/FCF Ratio32.76
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)2.78
Revenue Forecast (FY)€1.92B
Bulls Say, Bears Say
Bulls Say
Durable B2B Business ModelLISI's focus on engineered fasteners and assembled components for aerospace and automotive creates durable demand from long-life platform programs and series production. High technical certification and traceability requirements raise switching costs and support recurring contract revenue over multiple years.
Improved Balance Sheet LeverageDebt declining to under 50% of equity improves financial flexibility and reduces refinancing risk. This stronger leverage profile gives the company capacity to fund targeted capex, weather aerospace/auto cycles, and pursue selective investments without materially increasing vulnerability to downturns.
Solid Operating Profitability And ROESustained mid-single digit operating margins and double-digit ROE indicate the business can generate meaningful returns on capital despite cyclicality. Improved profitability versus the loss-making 2020 period shows structural operational improvement and the ability to convert engineering content into margin.
Bears Say
Recent Revenue DeclineRevenue weakening after multi-year growth highlights sensitivity to end-market cycles and program timing. If aerospace deliveries or auto series volumes remain soft, sustained top-line contraction would pressure margins, cash flow and make it harder to sustain returns and deleveraging progress.
Moderate Cash ConversionOperating cash flow and FCF trailing net income signal working-capital needs or investment absorption. Sub-50% FCF-to-earnings constrains balance-sheet strengthening, limits organic funding for growth or payouts, and increases dependence on external financing during tougher cycles.
Volatile MarginsPronounced margin swings reduce earnings predictability and complicate budgeting. In industries with material input, qualification and mix effects, such volatility can erode investor confidence and impair the firm's ability to commit to long-term investments or pricing strategies without risking profitability.
Lisi SA News
LI3 FAQ
What was Lisi SA’s price range in the past 12 months?
Lisi SA lowest stock price was €38.70 and its highest was €70.40 in the past 12 months.
What is Lisi SA’s market cap?
Lisi SA’s market cap is €3.04B.
When is Lisi SA’s upcoming earnings report date?
Lisi SA’s upcoming earnings report date is Feb 18, 2027 which is in 204 days.
How were Lisi SA’s earnings last quarter?
Lisi SA released its earnings results on Jul 23, 2026. The company reported €1.358 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Lisi SA overvalued?
According to Wall Street analysts Lisi SA’s price is currently Overvalued.
Does Lisi SA pay dividends?
Lisi SA does not currently pay dividends.
What is Lisi SA’s EPS estimate?
Lisi SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lisi SA have?
Lisi SA has 46,538,315 shares outstanding.
What happened to Lisi SA’s price movement after its last earnings report?
Lisi SA reported an EPS of €1.358 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.157%.
Which hedge fund is a major shareholder of Lisi SA?
Currently, no hedge funds are holding shares in DE:LI3
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Lisi SA
Lisi S.A. is a global provider of specialized assembly and component solutions, primarily serving the aerospace, automotive, and medical sectors. The company organizes its operations into three distinct divisions: LISI Aerospace, LISI Automotive, and LISI Medical. LISI Aerospace specializes in advanced aircraft components, including titanium fasteners, lightning protection, safety locking mechanisms, and fuse pins. Their contributions to the LEAP engine encompass compressor blades, struts, and composite fan blade leading edges. They also produce air intake lipskins for Airbus aircraft, semi-machined gears for power transmission, stator vanes, and satellite antenna mounting brackets for both airplanes and helicopters. LISI Automotive delivers a broad spectrum of fastening and component solutions for vehicles. This includes guide pins, electric parking brake elements, complete braking systems, and direct engine injection parts. They supply various fasteners like screws, nuts, and specialized clips for interior and exterior trim, alongside components for seat belt mechanisms, motor systems, and safety applications. The division also focuses on assembly optimization, offering cable ducts, battery fastening systems, intricate power transmission parts, and standard automotive fasteners. Furthermore, they provide clipped fastening solutions for both internal and external cladding, specialized fasteners for tubes and cables, and products designed to reduce weight and streamline assembly processes. Their portfolio extends to critical components for braking, fluid management, seat adjustment, and interior safety systems. LISI Medical is involved in the complete lifecycle of medical device development, from initial design and modeling through prototyping, pre-series production, material selection, process validation, and inventory management. They manufacture a range of orthopedic reconstruction implants for shoulders, hips, knees, and extremities, along with associated surgical instruments. The division also produces various surgical tools, such as blades, scissors, staplers, and pliers. Additionally, they provide spinal and trauma implants, including connectors, screws, cages, plates, and prostheses, specifically designed for treating trauma and facilitating osteosynthesis. Established in 1777, the company, originally known as GFI Industries, adopted the name LISI S.A. in 2002. Headquartered in Belfort, France, it operates as a subsidiary of Compagnie Industrielle De Delle S.A.